Arpigny, E. (2026). ADAMTS12, une protéase au carrefour du métabolisme lipidique et de la progression tumorale [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/340901 |
Joannes, L., Dupont, L., Stock, L., Arpigny, E., Hubert, P., Ancion, M., Luyckx, M., Abinet, J., Peng, W., Calaldo, D., Noël, A., Marichal, T., Herfs, M., Deroanne, C., & Colige, A. (23 June 2025). The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system. Cancer Cell International, 25 (1), 229. doi:10.1186/s12935-025-03880-1 |
Dekky, B.* , Azar, F.* , Bonnier, D., Monseur, C., Kalebić, C., Arpigny, E., Colige, A., Legagneux, V., & Théret, N. (November 2023). ADAMTS12 is a stromal modulator in chronic liver disease. FASEB Journal, 37 (11), 23237. doi:10.1096/fj.202200692RRRR * These authors have contributed equally to this work. |